Mapping of ER gene CpG island methylation by methylation-specific polymerase chain reaction

Cancer Research

Volumn 58, Issue 12, 1998, Pages 2515-2519

  Lapidus, Rena G ^a   Nass, Sharyl J ^a   Butash, Kimberly A ^a   Parl, Fritz F ^b   Weitzman, Sigmund A ^c   Graff, Jeremy G ^a   Herman, James G ^a   Davidson, Nancy E ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DINUCLEOTIDE; DNA; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; CPG ISLAND; GENE; GENE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENETIC MARKERS; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; TUMOR CELLS, CULTURED;

EID: 0032526094     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. McGuire, W. L. Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin. Oncol., 5: 428-433, 1978.
2. Lapidus, R. G., Nass, S. J., and Davidson, N. E. The loss of estrogen and progesterone receptor gene expression in human breast cancer. J. Mamm. Gland Biol. Neoplasia, 3: 85-94, 1998.
3. Bird, A. P. CpG-rich islands and the function of DNA methylation. Nature (Lond.), 321: 209-213, 1986.
4. Kass, S. U., Pruss, D., Wolffe, A. P. How does DNA methylation repress transcription? Trends Genet., 13: 444-449, 1997.
5. Li, K., Beard, C., and Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature (Lond.), 366: 362-365, 1993.
6. Laird, P. W., and Jaenisch, R. The role of DNA methylation in cancer genetics and epigenetics. Annu. Rev. Genet., 30: 441-464, 1996.
7. Counts, J. L., and Goodman, J. I. Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell, 83: 13-15, 1995.
8. Ottaviano, Y. L., Issa, J-P., Parl, F. F., Smith, H. S., Baylin, S. B., and Davidson, N. E. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res., 54: 2552-2555, 1994.
9. Lapidus, R. G., Ferguson, A. T., Ottaviano, Y. L., Parl, F. F., Smith, H. S., Weitzman, S. A., Baylin, S. B., Issa, J-P. J., and Davidson, N. E. Methylation of estrogen and progesterone receptor genes 5′ CpG islands correlates with lack of ER and PR gene expression in breast tumors. Clin. Cancer Res., 2: 805-810, 1996.
10. Ferguson, A. T., Lapidus, R. G., Baylin, S. B., and Davidson, N. E. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res., 55: 2279-2283, 1995.
11. Herman, J. G., Graft, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. MSP: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad Sci USA, 93: 9821-9826, 1996.
12. Bergstraessar, L. M., and Weitzman, S. A. Culture of normal and malignant primary human mammary epithelial cells in a physiologic manner simulates in vivo growth patterns and allows discrimination of cell type. Cancer Res., 53: 2644-2654, 1993.
13. Boyes, J., and Bird, A. Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. EMBO J., 11: 327-333, 1992.
14. Hsieh, C. L. Dependence of transcriptional repression on CpG methylation density Mol. Cell. Biol., 14: 5487-5494, 1994.
15. Walker, K. J., McClelland, R. A., Candlish, W., and Nicholson, R. I. Heterogeneity of oestrogen receptor expression in normal and malignant breast tissue. Eur. J. Cancer, 28: 34-37, 1992.
16. Nicholson, R. I., Bouzubar, N., Walker, K. J., McClelland, R., Dixon, A. R., Robertson, J. F. R., Ellis, I. O., and Blamey, R. W. Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation. Eur. J. Cancer, 27: 908-913, 1991.
17. Allegra, J. C., Barlock, A., Huff, K. K., and Lippman, M. E. Changes in multiple or sequential oestrogen receptor determination in breast cancer. Cancer (Phila.), 45: 792-794, 1980.
18. Samaan, N. A., Buzdar, A. V., Aldinger, K. A., Schultz, P. N., Yang, K., Romsdahl, M. M., and Martin, R. Estrogen receptor-a prognostic factor in breast cancer. Cancer (Phila.), 47: 554-560, 1981.
19. Kuukasjarvi, T., Kononen, J., Helin, K., Holli, K., and Isola, J. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. J. Clin. Oncol., 14: 2584-2589, 1996.
20. Jiang, S-Y., and Jordan, V. C. Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J. Natl. Cancer Inst., 84: 580-591, 1992.
21. Greene, G. L., Hilna, P., Waterfield, M., Baker, A., Hort, Y., and Shine, J. Sequence and expression of human estrogen receptor complementary DNA. Science (Washington DC), 231: 1150-1154, 1986.
22. Green, S., Walter, P., Kumar, V., Krust, A., Bornet, P-M., Argos, P., and Chambon, P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (Lond.), 320: 134-139, 1986.